Senior leaders will gather at the Oligonucleotides CMC & Analytical Development Summit to discuss improving analytical characterization, preparing CMC data for IND filing, and scaling up manufacturing for long-term success. The event aims to unlock the potential of oligonucleotides for treating large patient populations and undruggable targets. Despite recent advancements, challenges in manufacturability and regulatory protocols remain.